Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-11-008445
Filing Date
2011-11-10
Accepted
2011-11-10 17:30:42
Documents
13
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atheronova_10q-093011.htm 10-Q 894657
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 160182
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 309678
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 16905
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 17325
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 6752
7 EXHIBIT 32.2 ex32-2.htm EX-32.2 6761
  Complete submission text file 0001437749-11-008445.txt   3529669

Data Files

Seq Description Document Type Size
8 ahro-20110930.xml EX-101.INS 444779
9 ahro-20110930.xsd EX-101.SCH 15055
10 ahro-20110930_cal.xml EX-101.CAL 25236
11 ahro-20110930_def.xml EX-101.DEF 84300
12 ahro-20110930_lab.xml EX-101.LAB 121798
13 ahro-20110930_pre.xml EX-101.PRE 96442
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

EIN.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52315 | Film No.: 111196623
SIC: 2834 Pharmaceutical Preparations